Zoetis (ZTS)
(Delayed Data from NYSE)
$175.60 USD
+0.79 (0.45%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $175.30 -0.30 (-0.17%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Brokerage Reports
0 items in cart
Zoetis Inc. [ZTS]
Reports for Purchase
Showing records 181 - 200 ( 256 total )
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Sector Analysis Update: Clinical News Drives Vet Biotech Stock Performance
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
On January 12, 2016, Zoetis provided an update on the company?s tax outlook for 2016 and 2017 following the European Commission?s decision to reverse certain Belgium tax benefits.
Provider: G.RESEARCH, LLC
Analyst: KEDRA K